ASHG 2026 · Tools, software & services

Azenta at ASHG 2026

Name: ASHG 2026 Annual Meeting
Start: 2026-10-20
End: 2026-10-24
Location: Montréal

Burlington, Vermont

Azenta at ASHG 2026 in Montréal: 5 presentations (5 posters); Booth 1314.

presentations on the program

1314

exhibit booth

Explore everyone at ASHG 2026 →

Organization

ASHG 2026 Attendance

Azenta

Burlington, Vermont

1 Senior Product Manager, Next Generation Sequencing · 1 Director, US NGS & Clinical Services · 1 Senior Product Manager · 1 Business Process Manager, Azenta Life Sciences

genewiz.com|LinkedIn

Subsidiary

GENEWIZ sells genomics and multiomics services, custom DNA synthesis, and gene-to-discovery workflows. It serves researchers and life-science organizations.

Azenta appointed Martin Madaus as interim CEO after John Marotta resigned, a leadership change at Genewiz's parent company.

›

Azenta appointed Martin Madaus as interim CEO after John Marotta resigned, a leadership change at Genewiz's parent company.

2026-08 · source

Azenta appointed Trey Martin president of its Multiomics business, a new leadership contact for Genewiz's genomics services.

2026-04 · source

Azenta completed its acquisition of UK Biocentre, expanding Genewiz's biorepository and sample-storage capabilities.

2026-03 · source

Source: company newsroom

Parent Azenta Q3 FY2026 revenue $161M, up 12%

›

FY2026 guidance for continuing operations is $613M-$618M, signaling continued growth. · 2026-08-04

“Revenue was $161million, up 12% year over year. total reported revenue from continuing operations to range approximately between $613 to $618 million”

Source: results release

Currently hiring: 55 open roles

›

Source: careers page

Booth

Exhibiting at Booth 1314

Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm

Poster

Wed Oct 21
2:30 pm

Utilizing blood from PAXgene tubes for single nuclei transcriptomic analysis

Omics Technologies

TranscriptomeSingle-cellTranslational studies and preclinical trialsGenomics